Morgan Group Holding Co. (MGHL)
OTC PINK OTC PINK Primary 
JP Morgan has done an excellent job under Jamie Dimon's leadership, says RBC's Gerard Cassidy
Gerard Cassidy, RBC Capital Markets co-head of global financials research, joins CNBC's 'Squawk on the Street' to discuss big bank earnings reported this morning, his read on banking activity going into next year, and more.
JP Morgan's Jamie Dimon throws cold water on chatter he'll take US government post
The veteran banker's comments, which came as he announced expectation-beating Q3 profits, saw JP Morgan stock climb by 3% in morning trading on the New York Stock Exchange.
Morgan Stanley Thinks Blackwell Chips Could Generate $10 Billion in Sales for Nvidia by Q4. Here's 1 Other Figure I'm More Interested to See.
Nvidia's stock price may not see a significant boost given high valuation multiples, unless there are positive signs from insiders' behaviour.
What Is the Dividend Payout for Kinder Morgan?
Kinder Morgan offers investors a very attractive dividend yield.
Kinder Morgan Shuts Down Terminals in Tampa Over Hurricane Warning
KMI's Tampa Bay Stevedores, Tampaplex Terminal, and Port Sutton Terminal have been shut down due to Hurricane Milton, which is fast approaching landfall.
Solid Trading & IB Performance to Aid Morgan Stanley's Q3 Earnings
Improvement in trading and IB business performance is likely to have aided MS' Q3 earnings, while subdued NII is expected to have hurt.
Morgan Stanley Direct Lending: Likely To Become A Major Player Amongst Its Peers
Morgan Stanley Direct Lending Fund shows strong fundamentals and growth, with solid dividend coverage and a healthy portfolio, despite its short track record. MSDL's investment-grade credit ratings and manageable debt positions them well for future growth, but high exposure to floating rate loans poses risks. Trading at a slight discount to NAV, MSDL offers a compelling buy opportunity for income-oriented investors, though upside is limited due to potential rate declines.
Morgan Stanley's Strategic Reduction in Celcuity Inc Holdings
On September 30, 2024, Morgan Stanley executed a significant transaction involving the sale of 1,443,913 shares of Celcuity Inc (NASDAQ: CELC), a clinical-stage biotechnology company. This move reduced their holding by 50.92%, leaving them with 1,391,552 shares.
Morgan Stanley's Strategic Reduction in Replimune Group Inc Holdings
On September 30, 2024, Morgan Stanley executed a significant transaction involving the sale of 192,770 shares in Replimune Group Inc (REPL, Financial), a clinical-stage biotechnology company. This move reduced Morgan Stanley's holding by 11.11%, leaving the firm with a total of 1,542,884 shares.
Mobileye's stock is down 70% this year — and J.P. Morgan says it's not done falling
Four of 30 analysts are now bearish on the self-driving-technology stock, and the latest one sees about 20% further downside.
Invest with Confidence: Intrinsic Value Unveiled of Morgan Stanley
In this article, we will take a look into Morgan Stanley's (MS, Financial) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow as in the traditional DCF model, the GuruFocus DCF calculator uses EPS without NRI as the default for the DCF model based on research that shows that historically stock prices have been more correlated with earnings than free cash flow.
